Analysis of a cohort of 101 CDAII patients

description of 24 new molecular variants and genotype-phenotype correlations

Paola Bianchi, Klaus Schwarz, Josef Högel, Elisa Fermo, Cristina Vercellati, Regine Grosse, Richard van Wijk, Rob van Zwieten, Wilma Barcellini, Alberto Zanella, Hermann Heimpel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Congenital dyserythropoietic anaemia type II (CDAII) is a rare autosomal recessive disease characterized by ineffective erythropoiesis, haemolysis, erythroblast morphological abnormalities, hypoglycosylation of some red blood cell membrane proteins, particularly band 3, and mutations in the SEC23B gene. We report the analysis of 101 patients from 91 families with a median follow-up of 23 years (range 0–65); 68 patients are newly reported. Clinical and haematological parameters were separately analysed in early infancy and thereafter, when feasible. Molecular analysis of the SEC23B gene confirmed the high heterogeneity of the defect, leading to the identification of 54 different mutations, 24 of which are newly described. To evaluate the genotype-phenotype correlation, patients were grouped according to their genotype (two missense mutations vs. one missense/one drastic mutation) and assigned to two different severity gradings based on laboratory data and on therapeutic needs; by this approach only a weak genotype-phenotype correlation was observed in the analysed groups.

Original languageEnglish
Pages (from-to)696-704
Number of pages9
JournalBritish Journal of Haematology
Volume175
Issue number4
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Congenital Dyserythropoietic Anemia
Genetic Association Studies
Cohort Studies
Mutation
Erythrocyte Anion Exchange Protein 1
Erythroblasts
Erythropoiesis
Missense Mutation
Hemolysis
Genes
Membrane Proteins
Erythrocytes
Genotype
Therapeutics

Keywords

  • anaemia
  • CDAII
  • congenital dyserythropoietic anaemia type II
  • genotype/phenotype
  • red cell

ASJC Scopus subject areas

  • Hematology

Cite this

Analysis of a cohort of 101 CDAII patients : description of 24 new molecular variants and genotype-phenotype correlations. / Bianchi, Paola; Schwarz, Klaus; Högel, Josef; Fermo, Elisa; Vercellati, Cristina; Grosse, Regine; van Wijk, Richard; van Zwieten, Rob; Barcellini, Wilma; Zanella, Alberto; Heimpel, Hermann.

In: British Journal of Haematology, Vol. 175, No. 4, 01.11.2016, p. 696-704.

Research output: Contribution to journalArticle

Bianchi, Paola ; Schwarz, Klaus ; Högel, Josef ; Fermo, Elisa ; Vercellati, Cristina ; Grosse, Regine ; van Wijk, Richard ; van Zwieten, Rob ; Barcellini, Wilma ; Zanella, Alberto ; Heimpel, Hermann. / Analysis of a cohort of 101 CDAII patients : description of 24 new molecular variants and genotype-phenotype correlations. In: British Journal of Haematology. 2016 ; Vol. 175, No. 4. pp. 696-704.
@article{ff4be1f3388242c0ac047680e3c46282,
title = "Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations",
abstract = "Congenital dyserythropoietic anaemia type II (CDAII) is a rare autosomal recessive disease characterized by ineffective erythropoiesis, haemolysis, erythroblast morphological abnormalities, hypoglycosylation of some red blood cell membrane proteins, particularly band 3, and mutations in the SEC23B gene. We report the analysis of 101 patients from 91 families with a median follow-up of 23 years (range 0–65); 68 patients are newly reported. Clinical and haematological parameters were separately analysed in early infancy and thereafter, when feasible. Molecular analysis of the SEC23B gene confirmed the high heterogeneity of the defect, leading to the identification of 54 different mutations, 24 of which are newly described. To evaluate the genotype-phenotype correlation, patients were grouped according to their genotype (two missense mutations vs. one missense/one drastic mutation) and assigned to two different severity gradings based on laboratory data and on therapeutic needs; by this approach only a weak genotype-phenotype correlation was observed in the analysed groups.",
keywords = "anaemia, CDAII, congenital dyserythropoietic anaemia type II, genotype/phenotype, red cell",
author = "Paola Bianchi and Klaus Schwarz and Josef H{\"o}gel and Elisa Fermo and Cristina Vercellati and Regine Grosse and {van Wijk}, Richard and {van Zwieten}, Rob and Wilma Barcellini and Alberto Zanella and Hermann Heimpel",
year = "2016",
month = "11",
day = "1",
doi = "10.1111/bjh.14271",
language = "English",
volume = "175",
pages = "696--704",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "4",

}

TY - JOUR

T1 - Analysis of a cohort of 101 CDAII patients

T2 - description of 24 new molecular variants and genotype-phenotype correlations

AU - Bianchi, Paola

AU - Schwarz, Klaus

AU - Högel, Josef

AU - Fermo, Elisa

AU - Vercellati, Cristina

AU - Grosse, Regine

AU - van Wijk, Richard

AU - van Zwieten, Rob

AU - Barcellini, Wilma

AU - Zanella, Alberto

AU - Heimpel, Hermann

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Congenital dyserythropoietic anaemia type II (CDAII) is a rare autosomal recessive disease characterized by ineffective erythropoiesis, haemolysis, erythroblast morphological abnormalities, hypoglycosylation of some red blood cell membrane proteins, particularly band 3, and mutations in the SEC23B gene. We report the analysis of 101 patients from 91 families with a median follow-up of 23 years (range 0–65); 68 patients are newly reported. Clinical and haematological parameters were separately analysed in early infancy and thereafter, when feasible. Molecular analysis of the SEC23B gene confirmed the high heterogeneity of the defect, leading to the identification of 54 different mutations, 24 of which are newly described. To evaluate the genotype-phenotype correlation, patients were grouped according to their genotype (two missense mutations vs. one missense/one drastic mutation) and assigned to two different severity gradings based on laboratory data and on therapeutic needs; by this approach only a weak genotype-phenotype correlation was observed in the analysed groups.

AB - Congenital dyserythropoietic anaemia type II (CDAII) is a rare autosomal recessive disease characterized by ineffective erythropoiesis, haemolysis, erythroblast morphological abnormalities, hypoglycosylation of some red blood cell membrane proteins, particularly band 3, and mutations in the SEC23B gene. We report the analysis of 101 patients from 91 families with a median follow-up of 23 years (range 0–65); 68 patients are newly reported. Clinical and haematological parameters were separately analysed in early infancy and thereafter, when feasible. Molecular analysis of the SEC23B gene confirmed the high heterogeneity of the defect, leading to the identification of 54 different mutations, 24 of which are newly described. To evaluate the genotype-phenotype correlation, patients were grouped according to their genotype (two missense mutations vs. one missense/one drastic mutation) and assigned to two different severity gradings based on laboratory data and on therapeutic needs; by this approach only a weak genotype-phenotype correlation was observed in the analysed groups.

KW - anaemia

KW - CDAII

KW - congenital dyserythropoietic anaemia type II

KW - genotype/phenotype

KW - red cell

UR - http://www.scopus.com/inward/record.url?scp=84994475030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994475030&partnerID=8YFLogxK

U2 - 10.1111/bjh.14271

DO - 10.1111/bjh.14271

M3 - Article

VL - 175

SP - 696

EP - 704

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -